logo
Twitter
Discord
Email
logo
Photronics, Inc.

Photronics, Inc.

NASDAQ•PLAB
CEO: Dr. KangJyh Lee Ph.D.
Sector: Technology
Industry: Semiconductors
Listing Date: 1987-03-10
Photronics, Inc., together with its subsidiaries, engages in the manufacture and sale of photomask products and services in the United States, Taiwan, China, Korea, Europe, and internationally. It offers photomasks that are used in the manufacture of integrated circuits and flat panel displays (FPDs); and to transfer circuit patterns onto semiconductor wafers, and FDP substrates. The company offers electrical and optical components. It sells its products to semiconductor and FPD manufacturers, designers, and foundries, as well as to other high-performance electronics manufacturers through its sales personnel and customer service representatives. The company was formerly known as Photronic Labs, Inc. and changed its name to Photronics, Inc. in 1990. Photronics, Inc. was incorporated in 1969 and is based in Brookfield, Connecticut.
Contact Information
15 Secor Road, Brookfield, CT, 06804, United States
203-775-9000
www.photronics.com
Market Cap
$2.27B
P/E (TTM)
15.8
70.2
Dividend Yield
--
52W High
$38.10
52W Low
$16.46
52W Range
97%
Rank35Top 21.9%
5.0
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q4 2025 Data

Revenue

$215.77M-3.08%
4-Quarter Trend

EPS

$1.07+94.55%
4-Quarter Trend

FCF

$0.00+0.00%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Down Slightly Nine months revenue reached $633.5M, reflecting a 1.7% decrease compared to prior year period.
Shareholder Net Income Drops Net income attributable to shareholders was $74.6M YTD, a decrease of $22.2M versus prior year nine months.
Q3 Gross Margin Declines Q3 Gross Margin compressed to 33.7%, down 320 basis points from Q2 FY25 due to unfavorable product mix.
Cash Balances Decrease Total cash and equivalents ended period at $479.5M, reflecting a decrease from $598.5M at fiscal year end 2024.

Risk Factors

Tariffs Increase Trade Risk Ongoing U.S. tariff changes and investigations may increase supply chain costs and negatively affect product demand.
Currency Swings Hurt Income Foreign currency transactions resulted in a net expense of $(26.9M)$ YTD, driven by unfavorable New Taiwan dollar movements.
IC Revenue Faces Headwinds IC revenue fell 5.2% in Q3 versus Q2, reflecting geopolitical restrictions and continued headwinds in the Asian market.
Quarterly Earnings Contract Net income attributable to shareholders for the quarter was $22.9M, substantially lower than $34.4M reported in Q3 2024.

Outlook

FY2025 Capital Spending Planned Fiscal year 2025 capital expenditures estimated at $200M, targeted for high-end and mainstream capacity in Asia and U.S.
Share Repurchase Authorization $27.6M remains available for common stock repurchase, with potential utilization depending on prevailing market conditions.
Liquidity Sufficient for Future Liquidity, including available financing, is sufficient to meet requirements through next twelve months and beyond.
Evaluating New Accounting Rules Evaluating impact of ASU 2024-03 regarding expense disaggregation disclosures, effective for fiscal year 2028 reporting.

Peer Comparison

Revenue (TTM)

Lam Research CorporationLRCX
$19.59B
+25.7%
KLA CorporationKLAC
$12.52B
+22.2%
Entegris, Inc.ENTG
$3.22B
+0.6%

Gross Margin (Latest Quarter)

KLA CorporationKLAC
61.3%
+1.7pp
Nova Ltd.NVMI
56.7%
+0.1pp
Onto Innovation Inc.ONTO
50.7%
-3.4pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
LRCX$211.30B36.660.6%20.5%
KLAC$162.79B38.598.2%36.1%
ENTG$14.36B49.97.6%0.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
0.6%
Moderate Growth
4Q Net Income CAGR
13.0%
Profitability Improving
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Next earnings:Feb 24, 2026
|
EPS:-
|
Revenue:-
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Aug 3, 2025|Filed: Sep 9, 2025|
    Revenue: $210.39M-0.3%
    |
    EPS: $0.40-28.6%
    Beat
  • Form 10-Q - Q2 2025

    Period End: May 4, 2025|Filed: Jun 11, 2025|
    Revenue: $210.99M-2.8%
    |
    EPS: $0.15-74.6%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Feb 2, 2025|Filed: Mar 13, 2025|
    Revenue: $212.14M-1.9%
    |
    EPS: $0.69+60.5%
    Beat
  • Form 10-K - FY 2024

    Period End: Oct 31, 2024|Filed: Dec 19, 2024|
    Revenue: $866.95M-2.8%
    |
    EPS: $2.12+3.4%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Jul 28, 2024|Filed: Sep 5, 2024|
    Revenue: $210.98M-5.9%
    |
    EPS: $0.56+27.3%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Apr 28, 2024|Filed: Jun 7, 2024|
    Revenue: $217.00M-5.4%
    |
    EPS: $0.59-39.2%
    Meet
  • Form 10-Q - Q1 2024

    Period End: Jan 28, 2024|Filed: Mar 7, 2024|
    Revenue: $216.33M+2.5%
    |
    EPS: $0.43+87.0%
    Miss
  • Form 10-K - FY 2023

    Period End: Oct 31, 2023|Filed: Dec 26, 2023|
    Revenue: $892.08M+8.2%
    |
    EPS: $2.05-30.7%
    Beat